6 studies found for: "nephrogenic diabetes insipidus"
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Metformin and Congenital Nephrogenic Diabetes Insipidus
Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
|5||Not yet recruiting||
Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial
DILIPO (DILutIonal HyPOnatremia)
† Study has passed its completion date and status has not been verified in more than two years.